TAS::75 0849::TAS THE CONTRACTOR PROPOSES TO DEVELOP PHARMACODYNAMIC ASSAYS FOR
$999,913N44FY2010CANIH
Bioassay Systems, Llc, Hayward CA
Investigators
Abstract
The Contractor will develop pharmacodynamic assays for measuring a number of high-priority molecular targets. These assays will be suitable for pre-clinical and clinical testing to allow for rapid evaluation of treatment responses, gauge treatment correspondence to tumor stasis/regression, allow patient stratification for clinical trials and facilitate clinical validation of cancer therapeutics at early stages of drug development.
View original record on NIH RePORTER →